Yartemlea Injection
Product Images NDC 62225-300

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Yartemlea (NDC 62225-300). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Omeros Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (370mg Carton Label)

This text provides information about YARTEMLEA injection, containing narsoplimab-wuug. It is intended for intravenous infusion after dilution and must be stored refrigerated at 2°C to 8°C. The injection comes in a 2 mL single-dose vial containing 370 mg of narsoplimab-wuug and other ingredients. The recommended dosage is specified in the prescribing information. The product is manufactured by Omeros Corporation in Seattle, WA, with additional details regarding US Patent and License numbers provided.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.